Skip to the answer

Temozolomide Uses, Dosage, Side Effects and Interactions

Brand name
Temodar

Temodar was the first temozolomide product the FDA approved, in August 1999. The FDA rates no generic as a substitute for it.

Temozolomide is a chemotherapy drug used to treat certain aggressive brain tumors, including newly diagnosed glioblastoma and anaplastic astrocytoma, in adults.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 7, 2026 Where our facts come from

Quick links

Ask Anything About TemozolomideType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Temozolomide in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Temozolomide (Temodar) is a chemotherapy for aggressive brain tumors in adults, mainly glioblastoma and anaplastic astrocytoma, that damages the DNA inside cancer cells so they die; on the market since about 1999, with FDA-approved generics listed, it is the standard partner to radiation for newly diagnosed glioblastoma. It is fairly well tolerated for a chemotherapy, and nausea, tiredness, constipation and hair loss are the usual complaints. Its boxed warning covers dose mix-ups across its several capsule strengths, so check the strength and number of capsules in each package before every cycle. Expect regular blood tests, because it can seriously lower blood counts and, less often, damage the liver.

Key Takeaways From the HelloPharmacist Team

  • Expect a daily dose throughout radiation, then a dose on days 1 to 5 of each 28-day cycle during maintenance.
  • Swallow capsules whole with water on an empty stomach; never open or chew them, and wash off any powder that touches skin.
  • Call your care team right away for fever, chills, unusual bruising or bleeding, or new shortness of breath, especially if you take steroids.
  • Use effective birth control during treatment and for 6 months after for women, or condoms for 3 months after for men.

How we write and review this content: our editorial policy

Temozolomide by the Numbers

Strengths
7
across 2 forms
Makers and packagers
12
Earliest FDA record
1999
Rank by Medicaid prescriptions
#1,078 of 1,682 drugs
More prescriptions than 35% of the 1,682 drugs we measure
4,846 prescriptions, Q1–Q4 2025
Other forms and routes

Patient Information Guide for Temozolomide

What It’s Used For

Temozolomide is a chemotherapy drug approved for the treatment of certain malignant brain tumors in adults. The specific indications depend on the product and formulation:

  • Newly diagnosed glioblastoma — both Temodar (capsule and injection) and Temozolomide Capsules, USP are indicated for adults, given alongside focal radiation therapy and then continued as maintenance treatment
  • Adjuvant treatment of newly diagnosed anaplastic astrocytoma — Temodar (capsule and injection) is indicated for adults, beginning after completion of radiotherapy
  • Refractory anaplastic astrocytoma — Temodar (capsule and injection) is indicated for adults with this condition; Temozolomide Capsules, USP are specifically indicated for adults whose disease has progressed on a regimen containing nitrosourea and procarbazine

How It Works

Temozolomide is not active in its original form. Once it enters the body, it spontaneously converts — without needing liver enzymes — into a reactive compound that directly attacks DNA in cancer cells. This process (called DNA alkylation) damages the genetic material at specific sites, causes DNA strands to break, and triggers cancer cells to undergo programmed cell death. Normal liver enzymes play only a minor supporting role.

Drug Class

Drug Class

  • Alkylating Drug
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.

Drug Class

Established Pharmacologic Class (EPC)
  • Alkylating Drug

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)
  • Alkylating Activity

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)

None listed for Temozolomide in the FDA’s index.

From our Patient Information GuideTemozolomide is not active in its original form. Once it enters the body, it spontaneously converts — without needing liver enzymes — into a reactive compound that directly attacks DNA in cancer cells. Read How Temozolomide Works

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)

None listed for Temozolomide in the FDA’s index.

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Other alkylating agents

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

Temozolomide is taken once daily, either as a capsule by mouth or as an intravenous infusion over 90 minutes, depending on the product and treatment phase. Treatment generally follows one of two phases: a concomitant phase (given every day alongside radiation for several consecutive weeks) and a maintenance or adjuvant phase (given only on the first 5 days of a repeating 28-day cycle).

  • Capsules should be swallowed whole with a full glass of water; high-fat meals can reduce and delay absorption, so consistent timing relative to food matters
  • Blood counts must be checked regularly before and during treatment — your doctor may pause or adjust treatment based on those results
  • Always follow your prescriber's specific schedule and never adjust doses on your own

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Temozolomide Taken by Mouth

Newly diagnosed glioblastoma (a brain tumor)
Adults · Concomitant phase with radiotherapy Usual dose 75 mg/m2 once a day
  • 75 mg/m2 orally once daily for 42 to 49 days

Good to know

Provide PCP prophylaxis during this phase

PCP stands for pneumocystis pneumonia.

Adults · Maintenance, Cycle 1 Starting dose 150 mg/m2 once a day
  • 150 mg/m2 per day on days 1 to 5 of each 28-day cycle, beginning 4 weeks after concomitant phase completion
Adults · Maintenance, Cycles 2 to 6 Usual dose 200 mg/m2 once a day
  • May increase to 200 mg/m2 per day on days 1 to 5 before starting Cycle 2 if no dosage interruptions or discontinuations are required

Good to know

If not escalated at the onset of Cycle 2, do not increase for Cycles 3 to 6

Anaplastic astrocytoma (a brain tumor)
Adults with newly diagnosed disease, after radiotherapy · Cycle 1 Starting dose 150 mg/m2 once a day
  • 150 mg/m2 per day orally in a single dose on days 1 to 5 of a 28-day cycle for 12 cycles, beginning 4 weeks after the end of radiotherapy
Adults with newly diagnosed disease, after radiotherapy · Cycles 2 to 12 Usual dose 200 mg/m2 once a day
  • 200 mg/m2 per day on days 1 to 5 if patient experienced no or minimal toxicity in Cycle 1

Good to know

If not escalated at the onset of Cycle 2, do not increase during Cycles 3 to 6

Adults whose disease did not respond to other treatment Starting dose 150 mg/m2 once a day Usual dose 200 mg/m2 once a day

Step by step

  1. Initial dose 150 mg/m2 once daily on Days 1 to 5 of each 28-day cycle
  2. Increase to 200 mg/m2 per day if ANC is greater than or equal to 1.5 × 10^9/L and platelet count is greater than or equal to 100 × 10^9/L at the nadir and on Day 1 of the next cycle

Good to know

Reduce next cycle by 50 mg/m2 per day if ANC is less than 1 × 10^9/L or platelets less than 50 × 10^9/L

ANC stands for absolute neutrophil count.

See the Full Dosing Instructions on DailyMed →

Temozolomide Injection

Newly diagnosed glioblastoma (a brain tumor)
Adults · Concomitant phase with radiotherapy Usual dose 75 mg/m2 once a day
  • 75 mg/m2 intravenously once daily for 42 to 49 days

Good to know

Provide PCP prophylaxis during this phase

PCP stands for pneumocystis pneumonia.

Adults · Maintenance, Cycle 1 Starting dose 150 mg/m2 once a day
  • 150 mg/m2 per day intravenously on days 1 to 5 of each 28-day cycle, beginning 4 weeks after concomitant phase completion
Adults · Maintenance, Cycles 2 to 6 Usual dose 200 mg/m2 once a day
  • May increase to 200 mg/m2 per day on days 1 to 5 before starting Cycle 2 if no dosage interruptions or discontinuations are required

Good to know

If not escalated at the onset of Cycle 2, do not increase for Cycles 3 to 6

See the Full Dosing Instructions on DailyMed →

Side Effects

The most common side effects with temozolomide include:

Common side effects

  • Hair loss (alopecia)
  • Nausea and vomiting
  • Fatigue
  • Headache
  • Constipation
  • Loss of appetite (anorexia)
  • Seizures (convulsions)
  • Rash
  • Rash and dry skin

When to get medical help

  • Call your doctor right away if you develop unusual bruising, bleeding, or signs of infection (fever, chills) — these may signal dangerously low blood counts (myelosuppression)
  • Seek immediate help for shortness of breath or signs of a serious lung infection such as Pneumocystis pneumonia (PCP), especially if you are on steroids
  • Report yellowing of the skin or eyes, dark urine, or severe stomach pain — these can be signs of serious liver injury (hepatotoxicity)
  • Tell your care team immediately if you experience new or worsening neurological symptoms — secondary cancers including leukemia have been reported with temozolomide treatment
  • If a capsule is damaged and the powder contacts your skin or eyes, wash the area immediately with water and contact your care team

Serious reactions to watch for include dangerously low blood counts (which can cause infection, bleeding, or anemia), severe liver injury, a serious lung infection called Pneumocystis pneumonia, and — rarely — secondary cancers such as leukemia. Contact your care team immediately if you develop fever, unusual bleeding, yellowing of the skin or eyes, or breathing problems.

Warnings and Precautions

  • Low blood counts (myelosuppression): Temozolomide can seriously suppress the bone marrow, reducing white blood cells, platelets, and red blood cells. This can lead to life-threatening infections or bleeding. Women and older adults face a higher risk. Blood counts are monitored closely throughout treatment.
  • Liver damage (hepatotoxicity): Severe and fatal liver injury has been reported. Liver function tests are done at the start of treatment, throughout each cycle, and after completing treatment.
  • Pneumocystis pneumonia (PCP): A serious lung infection that can develop, especially in patients receiving steroids or on longer treatment courses. Preventive treatment may be prescribed, and all patients are monitored for this.
  • Secondary cancers: Cases of myelodysplastic syndrome and secondary leukemia have been observed after treatment with temozolomide-containing regimens.
  • Fetal harm: Temozolomide can cause severe birth defects or pregnancy loss. Effective contraception is required during treatment and for months afterward in both women and men.
  • Capsule safety: Never open, chew, or dissolve temozolomide capsules. If a capsule is damaged, avoid contact with the powder and wash any exposed area immediately.

Interactions

The number of significant drug interactions with temozolomide is relatively limited, but your care team should know about all your medications:

  • Valproic acid (used for seizures or mood disorders) — may slightly decrease the clearance of temozolomide, meaning more drug stays in the body; your team will monitor you closely
  • Dexamethasone, phenytoin, carbamazepine, phenobarbital, prochlorperazine, ondansetron, ranitidine, and other histamine-2 blockers — studies showed these did not meaningfully change how the body processes temozolomide, but always report every medication, supplement, and herbal product you take

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Do not take temozolomide if you have ever had a serious allergic reaction (including anaphylaxis) to temozolomide, dacarbazine, or any ingredient in the formulation — this is a contraindication
  • Tell your doctor if you are pregnant; temozolomide can cause serious fetal harm including malformations and pregnancy loss
  • Women who could become pregnant must have a pregnancy test before starting and must use effective contraception during treatment and for 6 months after the last dose
  • Men with pregnant partners or partners who could become pregnant must use condoms during treatment and for 3 months after the last dose, and must not donate semen during this time; temozolomide may affect male fertility
  • Do not breastfeed while taking temozolomide or for 1 week after the last dose — serious harm to a nursing infant is possible
  • Older adults (especially over age 65–70) and women are at higher risk for severe low blood counts and need closer monitoring
  • Safety and effectiveness have not been established in children
  • If you have severe kidney impairment (creatinine clearance below 36 mL/min) or end-stage kidney disease on dialysis, the appropriate dose is not established — discuss with your doctor
  • If you have severe liver impairment (Child-Pugh class C), the appropriate dose is not established — discuss with your doctor

Overdose

Taking too much temozolomide causes severe suppression of the bone marrow (myelosuppression), and at very high doses, can result in pancytopenia (dangerously low counts of all blood cell types), fever, multi-organ failure, and death. If an overdose is suspected, seek emergency medical help immediately. Treatment involves close monitoring of blood counts and supportive care.

Half-Life and How Your Body Processes It

After an oral dose, temozolomide is absorbed quickly, reaching peak blood levels in about 1 hour; a high-fat meal significantly slows and slightly reduces this absorption, so consistent dosing conditions matter. The drug has a short half-life of roughly 1.8 hours and is spontaneously converted in the body (not primarily by liver enzymes) into its active form. About 38% of a dose is recovered in the urine over 7 days, mostly as unchanged drug and breakdown products. The body handles temozolomide similarly regardless of age (19–78 years), sex, smoking status, or mild-to-moderate kidney or liver impairment; however, its behavior in patients with severe kidney or liver disease has not been well studied.

Storage

Store TEMODAR Capsules at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) . Store TEMODAR for injection refrigerated at 2°C to 8°C (36°F to 46°F).

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Supplements and Herbs That Interact With Temozolomide

From the licensed clinical database we use, rolled up per supplement, most serious first.

25 supplements and herbal products have documented interactions with Temozolomide in the licensed clinical database we use.

Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.

  • 1Major
  • 14Moderate
  • 10Minor

See the other 17

Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.

Nutrients Temozolomide May Deplete

Nutrients Temozolomide has been linked with lower levels of, from the licensed clinical database we use.

Temozolomide has been associated with lower levels of 1 nutrient in the clinical literature. This does not mean a deficiency will occur. It means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.

Educational information from a licensed clinical database (Natural Medicines), not medical advice. Do not start or stop medications or supplements without professional guidance.

Temozolomide: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Temozolomide — the kind of thing our pharmacy team would talk through with you at the counter.

What exactly is temozolomide treating, and why do I need it?

Temozolomide is a chemotherapy used to treat aggressive brain tumors — specifically glioblastoma (a fast-growing brain tumor) and anaplastic astrocytoma. It works by getting into cancer cells and damaging their DNA so they can no longer divide and grow. Depending on your diagnosis, your doctor may combine it with radiation or use it on its own. Your specific treatment plan will depend on which tumor you have and how your body responds.

How should I take the capsules — does it matter when I take them or whether I eat first?

Yes, it does matter. Swallow the capsules whole with a full glass of water — never open, crush, or chew them. Try to avoid taking them right after a high-fat meal, because fat can slow absorption and reduce how much of the drug gets into your system. Your doctor or pharmacist can guide you on the best timing. If you accidentally open or damage a capsule, avoid touching the powder and wash any exposed skin right away with water.

What side effects should I expect, and which ones mean I need to call my doctor?

The most common side effects are nausea, vomiting, fatigue, headache, hair loss, constipation, and poor appetite — these are expected and your team can help manage them. The ones to call about right away are fever, chills, unusual bruising or bleeding (signs your blood counts may be dangerously low), or shortness of breath (which could signal a serious lung infection). Yellowing of the skin or eyes, dark urine, or severe stomach pain could mean liver problems and also need immediate attention.

Why do I need so many blood tests while I'm on this medication?

Temozolomide can lower your white blood cells, red blood cells, and platelets — a condition called myelosuppression. These drops can happen without obvious symptoms at first, but they make you vulnerable to serious infections and bleeding. Regular blood tests let your team catch problems early and pause or adjust your dose before anything becomes life-threatening. Women and older adults are especially at risk, so monitoring is even more important for those patients.

Is it safe to get pregnant or father a child while on this treatment?

No — temozolomide can seriously harm a developing baby, including causing birth defects or pregnancy loss. If you could become pregnant, you need to use effective contraception throughout treatment and for 6 months after your last dose. If you're a man, you need to use condoms during treatment and for 3 months after your last dose, and avoid donating sperm during that time. There is also some evidence the drug can affect sperm. If pregnancy is a concern, talk to your doctor before starting treatment.

Can I breastfeed while taking temozolomide?

No. It is not safe to breastfeed while on temozolomide or for at least 1 week after your last dose. The drug could pass into breast milk and cause serious harm — including bone marrow suppression — in a nursing baby. Talk to your care team about your options for feeding your baby during and just after treatment.

Is temozolomide available over the counter?

No. Temozolomide is a prescription medicine: every temozolomide product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was temozolomide first available?

The earliest FDA record we hold for temozolomide is from 1999: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when temozolomide was first used.

Who makes temozolomide?

12 companies currently list temozolomide products in the FDA's NDC Directory, including Merck Sharp & Dohme LLC, Accord Healthcare Inc., Amneal Pharmaceuticals LLC. That count includes repackagers and distributors as well as manufacturers (companies that sell only the raw ingredient are not counted), so fewer companies actually make it; the label on your bottle names the one that supplied yours.

What is the brand name of temozolomide?

Temozolomide is the generic name. Its brand name is Temodar. Generic versions are listed under the name temozolomide.

What is the generic name of Temodar?

The generic name of Temodar is temozolomide. A generic name is the name of the active ingredient, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is temozolomide?

Temozolomide belongs to the drug class Alkylating Drug, its established pharmacologic class on the FDA label.

Is there a generic version of temozolomide?

Yes. FDA-approved generic versions of temozolomide are listed in the FDA's National Drug Code Directory. A listing does not prove that every pharmacy stocks one, so your pharmacy can tell you which version it carries.

What strengths does temozolomide come in?

Temozolomide is listed in the FDA's National Drug Code Directory in these forms and strengths. Capsule (by mouth): 5 mg, 20 mg, 100 mg, 140 mg, 180 mg and 250 mg. Injection (into a vein): 2.5 mg/mL. A listing does not mean every pharmacy stocks every strength.

How much does temozolomide cost?

What you pay depends on your insurance, your pharmacy and the strength you take. As a benchmark, pharmacies paid a national average of $0.88 to $20.53 per generic capsule across 3 strengths (most strengths about $4.07) as of November 18, 2026 (CMS's NADAC survey). That is the pharmacy's own cost for the medicine, not the price at the counter. No national price was found for temozolomide injections. The pharmacy prices section of this page lists every strength priced.

Is there a temozolomide shortage?

No. Temozolomide is not on the FDA's drug shortage list as of Nov 22, 2026. A single pharmacy can still run short for a while without a national shortage, and your pharmacist can tell you what they are seeing.

Where can I read the temozolomide prescribing information (package insert)?

The full FDA-approved prescribing information for temozolomide, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Merck Sharp & Dohme LLC's, revised Feb 20, 2026, and links to it on DailyMed.

Can you crush temozolomide?

Some forms of temozolomide are on our Do Not Crush list of tablets and capsules that should not be crushed or chewed: Temodar (capsule); temozolomide (capsule). Crushing or splitting a hazardous drug can expose whoever handles it. A form that is not on the list may still come with its own instructions, so check the label and ask your pharmacist before you crush, split or open any medicine. Each listed form’s reason and instructions are on our Do Not Crush list.

Is temozolomide gluten free?

No temozolomide label we read lists an ingredient made from wheat, barley or rye, the grains that carry gluten, and none names a starch, dextrin or maltodextrin without saying where it comes from. We read the FDA labels of 73 temozolomide products from 12 companies. A label lists ingredients; it is not a gluten test, so we cannot promise that any product has no gluten. If you have celiac disease, ask the company for a written gluten statement. Our Inactive Ingredient Checker shows each company's temozolomide by strength and NDC, and whether its label lists a gluten source, lactose, dyes or any other inactive ingredient. See temozolomide inactive ingredients by company

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Temozolomide

Skip the scrolling. Ask in your own words and get an answer from Temozolomide’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Temozolomide’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Temozolomide on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, as soon as they can.
Detailed Data & References for Temozolomide Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Temozolomide Forms and Strengths (How It Comes)

Temozolomide comes in 2 dose forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Temozolomide inactive ingredients by manufacturer.

Capsule

By mouth
Brands Temodar (the first brand, 1999)
How this form is used
What it may be used for
  • Temodar capsules are used for newly diagnosed glioblastoma alongside radiation and then as maintenance treatment in adults
  • Temodar capsules are used for adjuvant treatment of newly diagnosed anaplastic astrocytoma and for refractory anaplastic astrocytoma in adults
  • Temozolomide Capsules, USP are used for newly diagnosed glioblastoma alongside radiation and then as maintenance treatment in adults
  • Temozolomide Capsules, USP are used for refractory anaplastic astrocytoma in adults whose disease progressed after nitrosourea- and procarbazine-containing treatment
Important instructions
  • Swallow capsules whole with a full glass of water — do not open, chew, or dissolve them
  • Taking Temozolomide Capsules on an empty stomach (avoiding high-fat meals) leads to more consistent absorption
  • If a capsule is damaged, avoid contact with the powder — wash any exposed skin or mucous membranes immediately with water
  • Follow your prescriber's exact schedule; capsules are taken once daily either every day during the radiation phase or on set days within a 28-day cycle
Available strengths 6 strengths
72 FDA-listed product records ⓘ

Injection

Into a vein
Brands Temodar (the first brand, 1999)
How this form is used
What it may be used for
  • Temodar injection is used for newly diagnosed glioblastoma alongside radiation and then as maintenance treatment in adults
  • Temodar injection is used for adjuvant treatment of newly diagnosed anaplastic astrocytoma and for refractory anaplastic astrocytoma in adults
Important instructions
  • Temodar injection is given as an intravenous infusion (into a vein) over 90 minutes
  • Temodar injection is given once daily, either during the concomitant radiation phase or on specific days within a 28-day cycle, following your prescriber's schedule
Available strengths 1 strength
1 FDA-listed product record ⓘ

Temozolomide on the U.S. Market: Products, Makers and Brands

How Temozolomide appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

12 companies list 73 Temozolomide product records with the FDA, mostly as capsule, injection; the earliest marketing or approval year on record is 1999. The one brand name in the directory today is Temodar; the rest are generics.

2
Dose forms ⓘ
12
Labelers (makers, repackagers, distributors)
1
Brand names ⓘ
73
FDA-listed product records ⓘ
1999
Earliest FDA record ⓘ

FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

Also listed with the FDA, not a patient dose form: Powder (12) · Unfinished injection, powder, lyophilized, for solution (1) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.

Merck Sharp & Dohme LLC10%
Accord Healthcare Inc.8%
Amneal Pharmaceuticals LLC8%
Ascend Laboratories, LLC8%
Bryant Ranch Prepack8%
Camber Pharmaceuticals, Inc.8%
Other makers49%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How Widely Temozolomide Is Used (Medicaid Data)

How many Temozolomide prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

4,846
Medicaid prescriptions filled (Q1–Q4 2025)
$1.6M paid by Medicaid, before rebates

How commonly is Temozolomide prescribed? Of the 1,682 medications we measure, Temozolomide ranks #1,078 by Medicaid prescriptions — more than 36% of them.

Where Temozolomide ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Temozolomide product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

The 100 mg oral capsule is the most-dispensed Temozolomide product — about 37% of these Medicaid prescriptions.

temozolomide 100 MG Oral Capsule Most dispensed

1,810 Medicaid prescriptions (Q1–Q4 2025) 37% of Temozolomide prescriptions shown $524,538 paid by Medicaid, before rebates ≈ $290 per prescription, before rebates

9 of 49 listed NDCs had Medicaid claims. RxNorm 317160

temozolomide 140 MG Oral Capsule

818 Medicaid prescriptions (Q1–Q4 2025) 17% of Temozolomide prescriptions shown $280,534 paid by Medicaid, before rebates ≈ $343 per prescription, before rebates

8 of 54 listed NDCs had Medicaid claims. RxNorm 700883

temozolomide 250 MG Oral Capsule

543 Medicaid prescriptions (Q1–Q4 2025) 11% of Temozolomide prescriptions shown $165,405 paid by Medicaid, before rebates ≈ $305 per prescription, before rebates

4 of 35 listed NDCs had Medicaid claims. RxNorm 313210

temozolomide 5 MG Oral Capsule

459 Medicaid prescriptions (Q1–Q4 2025) 9% of Temozolomide prescriptions shown $25,244 paid by Medicaid, before rebates ≈ $55 per prescription, before rebates

7 of 55 listed NDCs had Medicaid claims. RxNorm 313211

temozolomide 20 MG Oral Capsule

453 Medicaid prescriptions (Q1–Q4 2025) 9% of Temozolomide prescriptions shown $40,728 paid by Medicaid, before rebates ≈ $90 per prescription, before rebates

11 of 57 listed NDCs had Medicaid claims. RxNorm 313209

temozolomide 180 MG Oral Capsule

433 Medicaid prescriptions (Q1–Q4 2025) 9% of Temozolomide prescriptions shown $158,320 paid by Medicaid, before rebates ≈ $366 per prescription, before rebates

7 of 53 listed NDCs had Medicaid claims. RxNorm 700885

temozolomide 100 MG Injection

330 Medicaid prescriptions (Q1–Q4 2025) 7% of Temozolomide prescriptions shown $449,499 paid by Medicaid, before rebates ≈ $1,362 per prescription, before rebates

1 of 1 listed NDCs had Medicaid claims. RxNorm 835945

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 47 of the 304 listed Temozolomide NDCs had Medicaid claims.

Compare Temozolomide Products

A representative set of FDA-listed product records for Temozolomide — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 73 of 73 products — FDA National Drug Code Directory. See every product, package size and price: browse all 73 Temozolomide NDCs →

Temozolomide Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list one Temozolomide recall since July 2021. It is still ongoing. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.

Ongoing Class II Mar 3, 2026 · Rising Pharma Holding, Inc.
Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing
  • Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Country of origin: Taiwan, NDC 16571-816-51. Lots: Lot #: 1TM0524003A, Exp. Date 09/2026. FDA record D-0384-2026 →

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Temozolomide in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.

Dose forms
2
Strengths
7
Forms in current FDA listings
2 of 2
In current FDA listings No current FDA listing
Ingredient (IN) Temozolomide RxCUI 37776
  1. Dose form (SCDF) Injection RxCUI 1724292
    In current FDA listings
    Its strength (SCD)
  2. Dose form (SCDF) Oral Capsule RxCUI 374610
    In current FDA listings
    Its 6 strengths (SCD)

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

What Temozolomide Costs Pharmacies (NADAC Benchmark)

What pharmacies pay to buy Temozolomide: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.

How the Pharmacy Price Has Changed

Pick a strength to see how its price has changed since Apr 2024.

Strength

For the generic 20 mg capsule, pharmacies paid an average of $0.880 per capsule as of Nov 18, 2026, down 79% from $4.11 a year earlier.

What pharmacies pay now
$0.880
per capsule, as of Nov 18, 2026
Last 4 weeks
No change
from $0.880 on Oct 21, 2026
Last 12 months
Down 79%
from $4.11 on Nov 19, 2025
Lowest and highest since Apr 2024
$0.880 to $4.81
per capsule

Each step is one weekly survey. Arrow keys on the chart move week by week.
See the numbers, month by month
Generic 20 mg capsule: the average pharmacy price per capsule, the last survey of each month
MonthPharmacy price
Nov 2026$0.880
Oct 2026$0.880
Sep 2026$0.880
Aug 2026$0.880
Jul 2026$0.880
Jun 2026$1.15
May 2026$1.43
Apr 2026$1.84
Mar 2026$1.90
Feb 2026$2.11
Jan 2026$4.11
Dec 2025$4.11
Nov 2025$4.11
Oct 2025$4.11
Sep 2025$4.11
Aug 2025$4.11
Jul 2025$4.11
Jun 2025$4.11
May 2025$4.11
Apr 2025$4.11
Mar 2025$4.11
Feb 2025$4.11
Jan 2025$4.81
Dec 2024$4.81
Nov 2024$4.81
Oct 2024$4.81
Sep 2024$4.81
Aug 2024$4.81
Jul 2024$4.81
Jun 2024$4.81
May 2024$4.81
Apr 2024$4.81
FormStrengthVersion What pharmacies pay
Capsule · Oral 20 mg Generic $0.880 per capsule NDC details & price history
Capsule · Oral 100 mg Generic $4.07 per capsule NDC details & price history
Capsule · Oral 250 mg Generic $20.53 per capsule NDC details & price history
Why it helps: it shows whether the drug itself is cheap or costly, and whether a cash price you are quoted is in a reasonable range. What you pay also depends on your insurance and pharmacy.

Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.

Temozolomide Brand Names

Temozolomide has one brand name on record: Temodar. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Temodar the first brand, 1999

Who Makes Temozolomide: Manufacturers and Labelers

12 companies list Temozolomide products with the FDA. By number of product records, the largest are Merck Sharp & Dohme LLC, Accord Healthcare Inc., Amneal Pharmaceuticals LLC. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Merck Sharp & Dohme LLC 7 Accord Healthcare Inc. 6 Amneal Pharmaceuticals LLC 6 Ascend Laboratories, LLC 6 Bryant Ranch Prepack 6 Camber Pharmaceuticals, Inc. 6 CivicaScript LLC 6 Devatis, Inc. 6 Nivagen Pharmaceuticals, Inc. 6 OPKO Pharmaceuticals, LLC 6 Rising Pharma Holdings, Inc. 6 Sun Pharmaceutical Industries, Inc. 6

Sources for This Temozolomide Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Feb 20, 2026, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Temozolomide.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 22 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
22
Finished products in the current FDA directory
73
Companies listing them (makers, repackagers, distributors)
12
FDA labeler codes behind them ⓘ
12
Linked representative label ⓘ
Merck Sharp & Dohme LLC
Linked label effective
Feb 20, 2026
Composite sections available
23
Linked SPL Set ID
046a9011-3911-4d3f-a15f-fbb56d5aad56
Linked SPL Document ID
40ceddc0-83a2-4b3b-8953-fd0078a41133
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Merck Sharp & Dohme LLC is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →